Search results
Results From The WOW.Com Content Network
Admission to Einstein's MD program is amongst the most competitive in the United States, with an acceptance rate of 1.87% in 2024. Einstein was one of the original three Medical Scientist Training Programs—which award MD/PhD degrees—to be awarded funding from the National Institutes of Health in 1964, and has received continuous funding since.
Stephen Waxman (Class of 1970, PhD and Class of 1972, MD), neurologist and neuroscientist, Bridget Flaherty Professor of Neurology, Neurobiology, and Pharmacology at Yale University. [42] [43] [44] Jonathan Zizmor (Class of 1969), dermatologist, known by millions of New York City subway riders for his quirky advertisements. [45] [46] [47]
Dr Sophie Molholm. Sophie Molholm (born 1966) is an American neuroscientist, who is the director of the Cognitive Neurophysiology Laboratory (CNL) and the Human Clinical Phenotyping Core (HCP) at the Albert Einstein College of Medicine in New York. [1]
The first research doctorate was the doctor of philosophy, which came to the U.S. from Germany, and is frequently referred to by its initials of Ph.D. As academia evolved in the country a wide variety of other types of doctoral degrees and programs were developed.
Ruth Levy Gottesman (née Levy, born 1930) is an American educator.Gottesman is the chair of the board of trustees of the Albert Einstein College of Medicine (AECOM) in the Bronx, New York, and a long-time professor there.
The program has its origins in the non-NIH funded MD-PhD training offered at the nation's research-centric medical schools. An early dual-degree program began at Case Western Reserve University School of Medicine in 1956. [4] Other prominent medical schools quickly followed this example and developed integrated MD-PhD training structures.
Ana Maria Cuervo (born 14 July 1966) is a Spanish-American physician, researcher, and cell biologist. She is a professor in developmental and molecular biology, anatomy and structural biology, and medicine and co-director of the Institute for Aging Studies at the Albert Einstein College of Medicine.
Tardiff joined the faculty at her alma mater, Albert Einstein College of Medicine, in 2001 as an assistant professor of medicine and physiology and biophysics. [1] During her tenure at the institution, she studied the basic molecular mechanisms that underlie the pathogenesis of cardiomyopathies caused by mutations in the cardiac thin filament in her lab. [2]